Back to results
CompletedPhase 2

Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects

NCT03406377

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Research Institute - Huntington Park

Huntington Park, California, United States

+2 additional locations

View on ClinicalTrials.gov
Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects — TrialFind